Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$758M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$460M |
| 3 |
Adobe
ADBE
|
+$352M |
| 4 |
Intercontinental Exchange
ICE
|
+$327M |
| 5 |
Ferguson
FERG
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.47B |
| 2 |
Cisco
CSCO
|
+$1.1B |
| 3 |
NVIDIA
NVDA
|
+$1.01B |
| 4 |
Microsoft
MSFT
|
+$914M |
| 5 |
Apple
AAPL
|
+$753M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.36% |
| 2 | Financials | 13.6% |
| 3 | Healthcare | 11.34% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
VirTra
VTSI
$38.2M
| $103K | ﹤0.01% |
25,278
+4,184
| +20% | +$25K |
|
3877
Purple Innovation
PRPL
$28.9M
| $103K | ﹤0.01% |
5,403
| – | – |
|
3878
Lantronix
LTRX
$275M
| $102K | ﹤0.01% |
40,866
-636
| -2% | -$2.05K |
|
|
ARTV
3879
Artiva Biotherapeutics
ARTV
$556M
| $99.9K | ﹤0.01% |
33,305
| – | – |
|
3880
Acumen Pharmaceuticals
ABOS
$177M
| $99.3K | ﹤0.01% |
90,258
-2,725
| -3% | -$3.89K |
|
3881
Invivyd
IVVD
$202M
| $97.6K | ﹤0.01% |
161,275
+1
| +0% | +$1 |
|
|
EQC
3882
DELISTED
Equity Commonwealth
EQC
| $95.9K | ﹤0.01% |
59,573
-2,658
| -4% | -$4.47K |
|
3883
Kyverna Therapeutics
KYTX
$499M
| $94.2K | ﹤0.01% |
48,784
+8,851
| +22% | +$26.2K |
|
|
TPIC
3884
DELISTED
TPI Composites
TPIC
| $93.9K | ﹤0.01% |
116,489
-1,910
| -2% | -$2.5K |
|
3885
Lantern Pharma
LTRN
$34.1M
| $93.7K | ﹤0.01% |
26,482
| – | – |
|
|
JBIO
3886
Jade Biosciences
JBIO
$1.49B
| $91.7K | ﹤0.01% |
1,044
-32
| -3% | -$2.81K |
|
|
AVR
3887
Anteris Technologies
AVR
$867M
| $90.9K | ﹤0.01% |
+24,965
| New | +$161K |
|
|
VCSA
3888
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $90.6K | ﹤0.01% |
16,842
-362
| -2% | -$1.87K |
|
3889
Nautilus Biotechnolgy
NAUT
$116M
| $87.9K | ﹤0.01% |
102,038
-4,659
| -4% | -$6.92K |
|
3890
Forafric Global
AFRI
$289M
| $87.5K | ﹤0.01% |
+10,174
| New | +$94.8K |
|
|
IGR
3891
CBRE Global Real Estate Income Fund
IGR
$713M
| $84.6K | ﹤0.01% |
16,403
+1
| +0% | +$5 |
|
3892
Amprius Technologies
AMPX
$1.76B
| $84.6K | ﹤0.01% |
31,554
+20,660
| +190% | +$60.9K |
|
3893
First Majestic Silver
AG
$9.25B
| $83.7K | ﹤0.01% |
+12,508
| New | +$74.5K |
|
3894
Tilly's
TLYS
$123M
| $82.9K | ﹤0.01% |
37,678
| – | – |
|
|
SUP
3895
DELISTED
Superior Industries International
SUP
| $82.9K | ﹤0.01% |
38,898
| – | – |
|
3896
KLX Energy Services
KLXE
$35.7M
| $82.8K | ﹤0.01% |
23,650
| – | – |
|
3897
Emergent Biosolutions
EBS
$234M
| $82.6K | ﹤0.01% |
17,003
+4,894
| +40% | +$40.5K |
|
|
AGEN
3898
Agenus
AGEN
$311M
| $82.4K | ﹤0.01% |
54,727
| – | – |
|
3899
Village Farms International
VFF
$309M
| $81.9K | ﹤0.01% |
135,467
| – | – |
|
3900
X4 Pharmaceuticals
XFOR
$434M
| $81.5K | ﹤0.01% |
11,492
| – | – |
|
Similar funds
Bank of New York Mellon's Q1 2025 Portfolio in Review
As of Q1 2025, Bank of New York Mellon held 4,232 positions worth $505B, down 6.7% from $541B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Bank of New York Mellon withdrew a net $15.2B in Q1 2025, closing 122 positions and reducing 2,490 holdings. Its most notable exit was Invesco S&P 500 Pure Value ETF, an estimated $123M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Bank of New York Mellon opened a new position in BNY Mellon Dynamic Value ETF worth $138M.
- Bank of New York Mellon's largest Q1 2025 buy was BNY Mellon Dynamic Value ETF: 5,452,259 shares worth $138M.
- Bank of New York Mellon added most to Johnson & Johnson in Q1 2025, an estimated $758M increase.
- Bank of New York Mellon's biggest Q1 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.47B.
- Bank of New York Mellon fully exited Invesco S&P 500 Pure Value ETF in Q1 2025, selling an estimated $123M.
- Bank of New York Mellon's ten largest holdings make up 23% of its $505B portfolio in Q1 2025.
- Bank of New York Mellon opened 116 new positions and closed 122 in Q1 2025.
- Bank of New York Mellon's portfolio value fell 6.7% quarter-over-quarter to $505B.
Based on Bank of New York Mellon's 13F filing for Q1 2025, filed 29 Apr 2025.